The presence or absence of T 4 -binding proteins in dialysates and ultrafiltrates, and the spurious free T 4 values that these proteins cause can be documented using a nonanalog free T 4 RIA.
Direct equilibrium dialysis and direct ultrafiltration-free thyroxine (T 4 ) methods use semipermeable membranes to separate free T 4 from T 4 -binding serum proteins. Nonanalog free T 4 RIAs measure this free T 4 . These measurements are based on [
125 I]T 4 binding to anti-T 4 and its displacement from anti-T 4 by unlabeled free T 4 (1) (2) (3) (4) 4 , yielding spurious results of these free T 4 assays (see Figure 1 in the Data Supplement that accompanies the online version of this Technical Brief at http://www.clinchem.ort/content/ vol53/issue5). The spurious free T 4 results caused by T 4 BSPs, and the protein concentrations at which they occur have not been reported. This study used T 4 -depleted serum proteins to obtain spurious free T 4 results and to determine the protein concentrations at which they occurred.
A nonanalog free T 4 RIA (Nichols Institute Diagnostics) and a total T 4 RIA (Coat-A-Count, Diagnostic Products Corp.) were used. A pool of normal human serum with thyroxine-binding globulin (TBG; 17 mg/L), transthyretin (0.27 g/L), albumin (42 g/L), total protein (78 g/L), total T 4 (94 nmol/L, 73 g/L), and dialyzable (free) T 4 (12.9 pmol/L, 10 ng/L) was obtained from Equitech-Bio. Anti-T 4 , anti-T 3, anti-IgG, and salicylates were undetectable. Adapting the method of Grundy et al. (5 ) , we used Amberlite IRA-410 anion exchange resin (Alfa Aesar) to strip 1 serum aliquot of T 4 . Another serum aliquot was ultrafiltered. Concentrations of these T 4 -depleted serum total proteins varied from 5 ϫ 10 Ϫ7 to 0.05 g/L. In addition, proteins concentrated by ultrafiltration were diluted with the corresponding ultrafiltrate to concentrations that varied from 40 -160 g/L. Highly purified human serum albumin (Ͼ99%, Sigma-Aldrich) and TBG (Ͼ95%, Cortex Biochem) were dissolved in T 4 -depleted human serum dialysate. Concentrations of albumin varied from 2 ϫ 10 Ϫ2 to 200 g/L and of TBG from 6 ϫ 10
Ϫ5
to 60 mg/L. Total and free T 4 were undetectable in these protein solutions.
The dialysis devices tested were a vertical membrane device using 10 mL of retentate and 10 mL of dialysate (Fisher Scientific) and a horizontal membrane device using 200 L of retentate and 2400 L of dialysate (Nichols Institute Diagnostics). According to the manufacturers, both devices use a regenerated cellulose membrane with a 12-14 kDa molecular weight cutoff (MWCO; Spectra/Por, Fisher Scientific). Membranes were washed with deionized water before use. The dialysis buffer used was reported previously (1 ) . To test for proteins in dialysates, T 4 -depleted human serum (40 -160 g/L) was dialyzed for 18 h at 37°C. During dialysis, mean (SD) pH was controlled to 7.4 (0.1) at 37°C by the HEPES contained in the dialysis buffer (6 ) . The final HEPES ion concentration was 54 mmol/L (1 ).
The ultrafiltration devices tested were the Centricon YM-10, Centricon YM-30, and Amicon Ultra-4 (Millipore). According to the manufacturer the regenerated cellulose membranes in these devices had MWCOs of 10 kDa, 30 kDa, and 10 kDa, respectively.
All devices were prerinsed with deionized water. Centrifugation was carried out in a temperature-controlled (37°C), fixed-angle rotor centrifuge at 3000g. Before ultrafiltration, T 4 -depleted serum pH was controlled to 7.4 (0.1) at 37°C, by addition of 40 L of 1200 mmol/L HEPES acid (Fisher Biotech) per milliliter of serum. Serum pH stability was obtained by 15 min of vortex-mixing at room temperature while a continuous stream of moist air passed across the serum. The final HEPES ion concentration was 54 mmol/L (1 ).
A 4th ultrafiltration device, the Centricon YM-100 device (Millipore), was used as a positive control. This device had a regenerated cellulose membrane with a MWCO of 100 kDa. T 4 binding serum proteins (T 4 BSPs) are expected to enter the ultrafiltrates obtained with this device because their molecular weights are 54 -66 kDa. The dialysate of T 4 -depleted human serum was used as the negative control.
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Clinical Chemistry 53, No. 5, 2007 Sodium levothyroxine (for injection) was obtained in 500-g vials (Bedford Labs) and dissolved in 5 mL of sodium chloride, USP, 9 g/L (Abbott Labs). This T 4 solution (125 mol/L, 100 mg/L) was diluted with T 4 -depleted human serum dialysate to concentrations ranging from 2.6 ϫ 10 Ϫ5 to 26 nmol/L (2 ϫ 10 Ϫ5 to 20 g/L). Free T 4 is often adsorbed from aqueous solutions onto solid surfaces. This adsorption was determined using the method of Holm et al. (7 ) for the test tubes (borosilicate glass) and screw-capped vials (borosilicate glass) used in the present study (Fisher Scientific). [
125 I]T 4 (Perkin-Elmer Life Sciences) was purified using Sephadex G-25 (SigmaAldrich) column chromatography (8 ) . The Sephadex columns were equilibrated to 0.01 mol/L phosphate-buffered saline (1 PBS tablet dissolved in 200 mL of water to obtain: 10 mmol/L phosphate buffer, 2.7 mmol/L potassium chloride, and 137 mmol/L sodium chloride; SigmaAldrich), at pH 5.4 and room temperature. A stock solution of [ 125 I]T 4 was added to the column and eluted with 100 mmol/L sodium hydroxide (Sigma-Aldrich). Fractions were collected in 13ϫ100 mm glass test tubes using an automated fraction collector (LKB). Gamma radiation was quantified using a multiwell, automated gamma counter (Gamma 4000, Beckman-Coulter). Adsorption was Ͻ0.4% in test tubes and vials.
A theoretical lower limit for the detection of displacements was calculated as the mean minus 2 SD of the zero control data. This limit was 0.001 mg/L for T 4 -depleted TBG, 0.025 g/L for T 4 -depleted albumin, and 0.0015 g/L for T 4 -depleted total protein, compared to 0.8 pmol/L (0.6 ng/L) for free T 4 . (See Fig. 2 in the online Data Supplement)
As a percentage of normal serum concentration, T 4 -depleted serum total protein concentrations and T 4 -depleted TBG concentrations were similarly effective in displacing [
125 I]T 4 , and both were more effective than T 4 -depleted albumin (Table 1) . We used T 4 -depleted serum total proteins, which contain all T 4 BSPs, to test for spurious free T 4 results in dialysates and ultrafiltrates.
When T 4 -depleted serum total proteins at concentrations ranging from 40 -160 g/L were applied to the 2 dialysis devices tested, no spurious free T 4 determinations were obtained. One of the 3 ultrafiltration devices yielded spurious free T 4 results (Fig. 1) which correlated with the concentrations of serum proteins in retentates (r ϭ 0.94; P ϭ 0.047). This result was unexpected because the designated MWCO was 10 kDa and the molecular weights of T 4 BSPs are 54 to 66 kDa. Spurious free T 4 determinations were obtained with the positive control, as expected (Fig. 1) .
Previous studies have measured albumin in serum dialysates or ultrafiltrates. Weeke et al. (9, 10 ) measured albumin in serum ultrafiltrates with a microalbuminuria RIA with a sensitivity of 0.001 g/L. They calculated that a leakage of 0.0015% of undiluted serum albumin would induce an error of ϳ5% in free T 4 determinations. With the free T 4 RIA method, the presence of 0.06% (0.025 g/L) serum albumin resulted in spurious free T 4 values of ϳ3% (0.5 pmol/L). Tikanoja et al. (11 ) measured albumin in serum ultrafiltrates using an albumin RIA with a detection limit of 8.0 ϫ 10 Ϫ4 g/L. They used a cutoff value for protein leakage of 0.005% of serum proteins, citing Weeke et al. (9 ) . Ultrafiltration devices that allowed Ͻ0.005% (0.002 g/L) of albumin into ultrafiltrates were regarded as acceptable. Only 1 device of 4 met this criterion. Again, this compares to the free T 4 RIA method for which 0.06% (0.025 g/L) of serum albumin resulted in spurious free T 4 values of ϳ3% (0.5 pmol/L).
Holm et al. (12 ) measured albumin in both serum dialysates and serum ultrafiltrates using a double antibody sandwich ELISA with a detection limit of 2.8 ϫ 10 Ϫ6 g/L. They found no detectable albumin in serum dialysates but found detectable albumin in the ultrafiltrates obtained with each of 5 different devices.
The previous studies measured protein concentrations by use of albumin assays that were more sensitive for detecting albumin than the free T 4 RIA method used in the present study (0.001 g/L, 8.0 ϫ 10 Ϫ4 g/L, and 2.8 ϫ 10 Ϫ6 g/L, compared to 0.025 g/L). The present method, however, detects the spurious free T 4 values caused by any and all T 4 BSPs as a consequence of binding radiolabeled T 4 .
Uncertainty about spurious free T 4 determinations as a consequence of T 4 BSP interference is unnecessary. The laboratory that applies such a free T 4 RIA to the quantification of T 4 in serum dialysates or serum ultrafiltrates can use the same RIA to rule in or rule out these spurious free T 4 values. Grant/funding support: No extramural funds were used for this study.
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